GRAL Stock Summary and Trading Ideas (Grail | NASDAQ:GRAL)

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

What symbol and exchange does Grail shares trade?

Grail trades on the NASDAQ stock market under the symbol GRAL.

What is Grail stock price doing today?

As of January 16, 2026, GRAL stock price declined to $96.70 with 700,294 million shares trading.

What is Grail's Beta?

GRAL has a beta of 3.01, meaning it tends to be more sensitive to market movements. GRAL has a correlation of 0.21 to the broad based SPY ETF.

How much is Grail worth?

GRAL has a market cap of $3.77 billion. This is considered a Mid Cap stock.

How much money does Grail make?

Last quarter Grail reported $36 million in Revenue and -$2.46 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.90.

What are the top ETFs holding Grail?

The top ETF exchange traded funds that GRAL belongs to (by Net Assets): XBI, IWM, VTI, IWN, VXF.

Is Grail (GRAL) a good investment?

GRAL has outperformed the market in the last year with a price return of +450.1% while the SPY ETF gained +17.9%. GRAL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +28.0% and +13.0%, respectively, while the SPY returned +4.3% and +1.4%, respectively.

What are the support and resistance levels for Grail (GRAL)?

GRAL support price is $93.17 and resistance is $101.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GRAL shares will trade within this expected range on the day.